Policy & Regulation
Nanommune & Velox Biosystems partnership to offer laboratory testing of COVID-19 serological assays
2 July 2020 -

Biotechnology company Nanommune Inc said on Wednesday that it will launch the rapid, high-throughput laboratory testing and consulting services in the global market in partnership with Velox Biosystems Inc in the fight against the ongoing COVID-19 pandemic.

The partnership will market its cutting-edge high plex microarray products in the global market in the fight against the ongoing COVID-19 pandemic. The researchers are developing treatments against COVID-19 and the use of high plex microarrays for SARS-CoV-2 research is gaining rapid adoption, however, many labs lack the capacity to perform the tests in an accurate and high-throughput manner.

Additionally, the partnership has years of experience in developing breakthrough diagnostic technologies and will now provide end-to-end testing and consulting services for their clients, clinicians, laboratories and researchers during the Corona crisis.



Related Headlines